Psychosis associated with usage of herbal slimming products adulterated with sibutramine: a case series

Context. Sibutramine, or its structurally related analogs, is often found as an adulterant in proprietary herbal slimming products in Hong Kong. A few solitary case reports of sibutramine-associated psychosis have been published since 2000. As the only tertiary referral center for clinical toxicolog...

Full description

Saved in:
Bibliographic Details
Published in:Clinical toxicology (Philadelphia, Pa.) Vol. 48; no. 8; pp. 832 - 838
Main Authors: Chen, Sammy P.L., Tang, Magdalene H.Y., Ng, Sau Wah, Poon, Wing Tat, Chan, Albert Y.W., Mak, Tony W.L.
Format: Journal Article
Language:English
Published: England Informa Healthcare 01-10-2010
Taylor & Francis
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Context. Sibutramine, or its structurally related analogs, is often found as an adulterant in proprietary herbal slimming products in Hong Kong. A few solitary case reports of sibutramine-associated psychosis have been published since 2000. As the only tertiary referral center for clinical toxicology analysis in Hong Kong, we noticed that psychosis was an unusually common feature in patients taking "herbal slimming products" adulterated with sibutramine or its structurally related analogs over the past 5 years. Objective. To examine the association between psychosis and the use of sibutramine-adulterated herbal products, in an attempt to elucidate this possible adverse drug reaction. Methods. This retrospective study reviewed all cases hospitalized with psychotic symptoms confirmed to have used herbal slimming products adulterated with sibutramine, or its analogs, between January 2004 and October 2009. The cases' clinical features, outcome, drug history, and analytical findings of the offending slimming products were studied. Results. Among the 16 confirmed cases, 15 (94%) were female; the median age was 19 years (range: 15-47). Auditory hallucination was documented in 10 (63%), visual hallucination in 6 (38%), persecutory ideas in 6 (38%), delusions in 4 (25%), and suicidal ideation in 2 (13%). For 20 "herbal" slimming products analyzed, 16 were found to have been adulterated with sibutramine, 2 with N-desmethyl-sibutramine, and 1 with N-bisdesmethyl-sibutramine. Other concomitant adulterants were also found and included phenolphthalein in 9, fenfluramine, mazindol, animal thyroid tissue in 2, hydrochlorothiazide and spironolactone in 1. Eight patients disclosed the source of the products: four through the Internet, one obtained over-the-counter locally, with three acquired outside Hong Kong. Conclusion. Slimming products claimed "herbal" in origin could often be adulterated with sibutramine and other Western medications. We observed an association between the use of these products and psychotic features. Further studies are warranted to study whether these adverse events are an uncommon adverse drug reaction of sibutramine.
AbstractList Sibutramine, or its structurally related analogs, is often found as an adulterant in proprietary herbal slimming products in Hong Kong. A few solitary case reports of sibutramine-associated psychosis have been published since 2000. As the only tertiary referral center for clinical toxicology analysis in Hong Kong, we noticed that psychosis was an unusually common feature in patients taking "herbal slimming products" adulterated with sibutramine or its structurally related analogs over the past 5 years. To examine the association between psychosis and the use of sibutramine-adulterated herbal products, in an attempt to elucidate this possible adverse drug reaction. This retrospective study reviewed all cases hospitalized with psychotic symptoms confirmed to have used herbal slimming products adulterated with sibutramine, or its analogs, between January 2004 and October 2009. The cases' clinical features, outcome, drug history, and analytical findings of the offending slimming products were studied. Results. Among the 16 confirmed cases, 15 (94%) were female; the median age was 19 years (range: 15-47). Auditory hallucination was documented in 10 (63%), visual hallucination in 6 (38%), persecutory ideas in 6 (38%), delusions in 4 (25%), and suicidal ideation in 2 (13%). For 20 "herbal" slimming products analyzed, 16 were found to have been adulterated with sibutramine, 2 with N-desmethyl-sibutramine, and 1 with N-bisdesmethyl-sibutramine. Other concomitant adulterants were also found and included phenolphthalein in 9, fenfluramine, mazindol, animal thyroid tissue in 2, hydrochlorothiazide and spironolactone in 1. Eight patients disclosed the source of the products: four through the Internet, one obtained over-the-counter locally, with three acquired outside Hong Kong. Slimming products claimed "herbal" in origin could often be adulterated with sibutramine and other Western medications. We observed an association between the use of these products and psychotic features. Further studies are warranted to study whether these adverse events are an uncommon adverse drug reaction of sibutramine.
Context. Sibutramine, or its structurally related analogs, is often found as an adulterant in proprietary herbal slimming products in Hong Kong. A few solitary case reports of sibutramine-associated psychosis have been published since 2000. As the only tertiary referral center for clinical toxicology analysis in Hong Kong, we noticed that psychosis was an unusually common feature in patients taking "herbal slimming products" adulterated with sibutramine or its structurally related analogs over the past 5 years. Objective. To examine the association between psychosis and the use of sibutramine-adulterated herbal products, in an attempt to elucidate this possible adverse drug reaction. Methods. This retrospective study reviewed all cases hospitalized with psychotic symptoms confirmed to have used herbal slimming products adulterated with sibutramine, or its analogs, between January 2004 and October 2009. The cases' clinical features, outcome, drug history, and analytical findings of the offending slimming products were studied. Results. Among the 16 confirmed cases, 15 (94%) were female; the median age was 19 years (range: 15-47). Auditory hallucination was documented in 10 (63%), visual hallucination in 6 (38%), persecutory ideas in 6 (38%), delusions in 4 (25%), and suicidal ideation in 2 (13%). For 20 "herbal" slimming products analyzed, 16 were found to have been adulterated with sibutramine, 2 with N-desmethyl-sibutramine, and 1 with N-bisdesmethyl-sibutramine. Other concomitant adulterants were also found and included phenolphthalein in 9, fenfluramine, mazindol, animal thyroid tissue in 2, hydrochlorothiazide and spironolactone in 1. Eight patients disclosed the source of the products: four through the Internet, one obtained over-the-counter locally, with three acquired outside Hong Kong. Conclusion. Slimming products claimed "herbal" in origin could often be adulterated with sibutramine and other Western medications. We observed an association between the use of these products and psychotic features. Further studies are warranted to study whether these adverse events are an uncommon adverse drug reaction of sibutramine.
CONTEXTSibutramine, or its structurally related analogs, is often found as an adulterant in proprietary herbal slimming products in Hong Kong. A few solitary case reports of sibutramine-associated psychosis have been published since 2000. As the only tertiary referral center for clinical toxicology analysis in Hong Kong, we noticed that psychosis was an unusually common feature in patients taking "herbal slimming products" adulterated with sibutramine or its structurally related analogs over the past 5 years.OBJECTIVETo examine the association between psychosis and the use of sibutramine-adulterated herbal products, in an attempt to elucidate this possible adverse drug reaction.METHODSThis retrospective study reviewed all cases hospitalized with psychotic symptoms confirmed to have used herbal slimming products adulterated with sibutramine, or its analogs, between January 2004 and October 2009. The cases' clinical features, outcome, drug history, and analytical findings of the offending slimming products were studied. Results. Among the 16 confirmed cases, 15 (94%) were female; the median age was 19 years (range: 15-47). Auditory hallucination was documented in 10 (63%), visual hallucination in 6 (38%), persecutory ideas in 6 (38%), delusions in 4 (25%), and suicidal ideation in 2 (13%). For 20 "herbal" slimming products analyzed, 16 were found to have been adulterated with sibutramine, 2 with N-desmethyl-sibutramine, and 1 with N-bisdesmethyl-sibutramine. Other concomitant adulterants were also found and included phenolphthalein in 9, fenfluramine, mazindol, animal thyroid tissue in 2, hydrochlorothiazide and spironolactone in 1. Eight patients disclosed the source of the products: four through the Internet, one obtained over-the-counter locally, with three acquired outside Hong Kong.CONCLUSIONSlimming products claimed "herbal" in origin could often be adulterated with sibutramine and other Western medications. We observed an association between the use of these products and psychotic features. Further studies are warranted to study whether these adverse events are an uncommon adverse drug reaction of sibutramine.
Author Poon, Wing Tat
Tang, Magdalene H.Y.
Mak, Tony W.L.
Chen, Sammy P.L.
Chan, Albert Y.W.
Ng, Sau Wah
Author_xml – sequence: 1
  givenname: Sammy P.L.
  surname: Chen
  fullname: Chen, Sammy P.L.
  email: makwl@ha.org.hk, makwl@ha.org.hk
  organization: Hospital Authority Toxicology Reference Laboratory, Princess Margaret Hospital, Hong Kong Special Administrative Region, China
– sequence: 2
  givenname: Magdalene H.Y.
  surname: Tang
  fullname: Tang, Magdalene H.Y.
  email: makwl@ha.org.hk, makwl@ha.org.hk
  organization: Hospital Authority Toxicology Reference Laboratory, Princess Margaret Hospital, Hong Kong Special Administrative Region, China
– sequence: 3
  givenname: Sau Wah
  surname: Ng
  fullname: Ng, Sau Wah
  email: makwl@ha.org.hk, makwl@ha.org.hk
  organization: Hospital Authority Toxicology Reference Laboratory, Princess Margaret Hospital, Hong Kong Special Administrative Region, China
– sequence: 4
  givenname: Wing Tat
  surname: Poon
  fullname: Poon, Wing Tat
  email: makwl@ha.org.hk, makwl@ha.org.hk
  organization: Hospital Authority Toxicology Reference Laboratory, Princess Margaret Hospital, Hong Kong Special Administrative Region, China
– sequence: 5
  givenname: Albert Y.W.
  surname: Chan
  fullname: Chan, Albert Y.W.
  email: makwl@ha.org.hk, makwl@ha.org.hk
  organization: Hospital Authority Toxicology Reference Laboratory, Princess Margaret Hospital, Hong Kong Special Administrative Region, China
– sequence: 6
  givenname: Tony W.L.
  surname: Mak
  fullname: Mak, Tony W.L.
  email: makwl@ha.org.hk, makwl@ha.org.hk
  organization: Hospital Authority Toxicology Reference Laboratory, Princess Margaret Hospital, Hong Kong Special Administrative Region, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20969504$$D View this record in MEDLINE/PubMed
BookMark eNp9kE1r3DAQhkVJaD7af1CKbj1tIn_ItnpoCSFtAoH20J7FeDReK8hWqrEJ--9js5uWXnKSGJ73neE5E0djHEmID5m6KDJlLjOtq6LS6iJXy0hnda6aN-J0HW-MzszR4b8yJ-KM-UGpoilN9lac5MpURqvyVGx_8g77yJ4lMEf0MJGTT37q5cywJRk72VNqIUgOfhj8uJWPKboZpyXh5jBR-hdh385TgoWizxIkApNkSp74nTjuIDC9P7zn4ve3m1_Xt5v7H9_vrq_uN1hm9bTpsG4IEDEnqHWlERpTocHalOi0ayEvMS_QUVuozDVl2ymlSgfKQekqpOJcfNr3Lkf-mYknO3hGCgFGijPbulJ5ketKLWS5JzFF5kSdfUx-gLSzmbKrYfti2K6G7d7wEvt4WDC3A7m_oRelC_B1D_ixi2mAp5iCsxPsQkxdghE9r_WvrvjyX0NPEKYeIZF9iHMaF3-v3_gMPMaikw
CitedBy_id crossref_primary_10_1177_0960327112436407
crossref_primary_10_1016_j_jpba_2011_09_036
crossref_primary_10_1007_s11419_021_00609_3
crossref_primary_10_1007_s00216_020_02944_7
crossref_primary_10_1002_jcp_27266
crossref_primary_10_1016_j_phymed_2024_155667
crossref_primary_10_1039_C4RA09636C
crossref_primary_10_1016_j_jpba_2012_02_014
crossref_primary_10_1007_s12231_012_9211_6
crossref_primary_10_1111_bcp_13420
crossref_primary_10_1080_15563650_2020_1822529
crossref_primary_10_3390_molecules26226903
crossref_primary_10_1111_j_2042_7166_2010_01072_x
crossref_primary_10_1016_j_fct_2016_06_018
crossref_primary_10_3390_s17071601
crossref_primary_10_1002_dta_1980
crossref_primary_10_1016_j_ajp_2018_06_016
crossref_primary_10_1177_102490791101800406
crossref_primary_10_1542_pir_2016_0210
crossref_primary_10_1080_19440049_2014_958574
crossref_primary_10_1002_elps_201400059
crossref_primary_10_1007_s11419_020_00564_5
Cites_doi 10.1080/15563650903206844
10.1016/0006-3223(94)91200-9
10.1002/rcm.2876
10.1176/appi.ajp.157.12.2057-a
10.1016/0376-8716(91)90052-Z
10.1017/S1461145702003000
10.1016/j.jpsychores.2008.09.013
10.1345/aph.18319
10.1176/jnp.2007.19.1.88
10.1111/j.1467-789X.2009.00581.x
10.7326/0003-4819-145-2-200607180-00005
10.1136/bmj.c477
10.1097/JCP.0b013e31815ac4c0
10.1016/j.jpsychores.2007.05.014
10.1176/ajp.154.11.1624
10.1046/j.1467-789x.2000.00020.x
ContentType Journal Article
Copyright 2010 Informa UK, Ltd. 2010
Copyright_xml – notice: 2010 Informa UK, Ltd. 2010
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.3109/15563650.2010.517208
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1556-9519
EndPage 838
ExternalDocumentID 10_3109_15563650_2010_517208
20969504
517208
Genre ArticlesPoisons Centre Activitie
Journal Article
GroupedDBID ---
.GJ
00X
03L
0BK
0R~
29B
34G
36B
39C
3O-
4.4
53G
5RE
5VS
AAJNR
AALIY
AALUX
AAMIU
AAPUL
AAQRR
ABBKH
ABCRQ
ABDBF
ABEIZ
ABLKL
ABPTK
ABUPF
ACENM
ACFUF
ACGFS
ACLSK
ADCVX
ADFCX
ADRBQ
AECIN
AENEX
AEOZL
AEYQI
AFKVX
AFWLO
AGAFX
AGDLA
AGFJD
AGRBW
AGYJP
AIJEM
AIRBT
AJEBJ
AJWEG
AKBVH
ALIIL
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AWYRJ
BABNJ
BLEHA
BOHLJ
CAG
CCCUG
COF
DEIEU
DKSSO
DTRLO
DU5
DZHFC
EAP
EAS
EBC
EBD
EBS
EDH
EHN
EJD
EMB
EMK
EMOBN
EPL
EPT
ESX
F5P
H13
HZ~
J.N
KRBQP
KSSTO
KWAYT
KYCEM
LJTGL
LSO
M44
M4Z
O9-
QRXOQ
Q~Q
RNANH
RVRKI
SV3
TFDNU
TFL
TFW
TUS
UHWXJ
V1S
~1N
ABJNI
ABLIJ
ABXYU
ACIEZ
ALYBC
CGR
CUY
CVF
ECM
EIF
NPM
NUSFT
TBQAZ
TDBHL
TERGH
TUROJ
AAYXX
ACKYO
CITATION
7X8
ID FETCH-LOGICAL-c417t-fc78eaccc2ea7565ca896c9c794cd5dba24c23cdeb301d84bf0004da0da4d6ce3
ISSN 1556-3650
IngestDate Fri Oct 25 23:10:29 EDT 2024
Thu Nov 21 21:53:02 EST 2024
Tue Oct 15 23:36:40 EDT 2024
Tue Jun 13 19:57:40 EDT 2023
Tue May 16 09:19:55 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c417t-fc78eaccc2ea7565ca896c9c794cd5dba24c23cdeb301d84bf0004da0da4d6ce3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 20969504
PQID 760232560
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_760232560
pubmed_primary_20969504
crossref_primary_10_3109_15563650_2010_517208
informaworld_taylorfrancis_310_3109_15563650_2010_517208
informahealthcare_journals_10_3109_15563650_2010_517208
PublicationCentury 2000
PublicationDate 2010-10-01
PublicationDateYYYYMMDD 2010-10-01
PublicationDate_xml – month: 10
  year: 2010
  text: 2010-10-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Clinical toxicology (Philadelphia, Pa.)
PublicationTitleAlternate Clin Toxicol (Phila)
PublicationYear 2010
Publisher Informa Healthcare
Taylor & Francis
Publisher_xml – name: Informa Healthcare
– name: Taylor & Francis
References Muller D (CIT0004) 2009; 106
CIT0010
CIT0021
CIT0020
Yuen YP (CIT0005) 2007; 13
CIT0012
CIT0023
CIT0011
Gazdag G (CIT0014) 2008; 10
CIT0022
CIT0002
CIT0024
CIT0015
CIT0007
CIT0018
CIT0006
CIT0017
CIT0009
CIT0008
References_xml – ident: CIT0006
  doi: 10.1080/15563650903206844
– ident: CIT0023
  doi: 10.1016/0006-3223(94)91200-9
– volume: 10
  start-page: 107
  issue: 2
  year: 2008
  ident: CIT0014
  publication-title: Neuropsychopharmacol Hung
  contributor:
    fullname: Gazdag G
– ident: CIT0015
  doi: 10.1002/rcm.2876
– ident: CIT0007
  doi: 10.1176/appi.ajp.157.12.2057-a
– ident: CIT0022
  doi: 10.1016/0376-8716(91)90052-Z
– ident: CIT0008
  doi: 10.1017/S1461145702003000
– ident: CIT0012
  doi: 10.1016/j.jpsychores.2008.09.013
– ident: CIT0002
  doi: 10.1345/aph.18319
– volume: 13
  start-page: 216
  issue: 3
  year: 2007
  ident: CIT0005
  publication-title: Hong Kong Med J
  contributor:
    fullname: Yuen YP
– ident: CIT0010
  doi: 10.1176/jnp.2007.19.1.88
– ident: CIT0018
  doi: 10.1111/j.1467-789X.2009.00581.x
– ident: CIT0017
  doi: 10.7326/0003-4819-145-2-200607180-00005
– ident: CIT0020
  doi: 10.1136/bmj.c477
– ident: CIT0009
  doi: 10.1097/JCP.0b013e31815ac4c0
– ident: CIT0011
  doi: 10.1016/j.jpsychores.2007.05.014
– ident: CIT0024
  doi: 10.1176/ajp.154.11.1624
– ident: CIT0021
  doi: 10.1046/j.1467-789x.2000.00020.x
– volume: 106
  start-page: 218
  issue: 13
  year: 2009
  ident: CIT0004
  publication-title: Dtsch Arztebl Int
  contributor:
    fullname: Muller D
SSID ssj0038491
Score 2.1261158
Snippet Context. Sibutramine, or its structurally related analogs, is often found as an adulterant in proprietary herbal slimming products in Hong Kong. A few solitary...
Sibutramine, or its structurally related analogs, is often found as an adulterant in proprietary herbal slimming products in Hong Kong. A few solitary case...
CONTEXTSibutramine, or its structurally related analogs, is often found as an adulterant in proprietary herbal slimming products in Hong Kong. A few solitary...
SourceID proquest
crossref
pubmed
informaworld
informahealthcare
SourceType Aggregation Database
Index Database
Publisher
StartPage 832
SubjectTerms Adolescent
Adult
Anti-Obesity Agents - toxicity
Chinese medicine
Cyclobutanes - toxicity
Drug Contamination
Drugs, Chinese Herbal - toxicity
Female
Humans
Male
Middle Aged
Psychoses, Substance-Induced - etiology
Psychosis
Retrospective Studies
Sibutramine
Title Psychosis associated with usage of herbal slimming products adulterated with sibutramine: a case series
URI https://www.tandfonline.com/doi/abs/10.3109/15563650.2010.517208
https://www.ncbi.nlm.nih.gov/pubmed/20969504
https://search.proquest.com/docview/760232560
Volume 48
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj5swELayu5dKVbV9py_50FtESsGA6W2VpsqhG0XaVNuekLGd3R5IVgmR2n_fGcYGutu31AuKjIyB-ZhXZj4z9tLqKM4SZH5cAYKFFiqQIrFBYsDZSE2Ym4Z2cXaWzT_Kt1MxHQz8HnXd2H-VNIyBrLFz9i-k3V4UBuA3yByOIHU4_pHcSaMhzYhyb94XmO-xhoycwy2SgICHWVXUjN6wvu6IjANZlv2UHe6GtVUVspE2XdEajN4In8OVHnqOA99fWW--fNZE6wSuK2ZrkIby6pJKchdq3Ms8TFxjyJmqqq-jxfj9uEsjkAY6VRdY7wx-8Gz8qT07pwS32o_Ou2T2YkPlA-f4QEtV97MZWBkS9rMZyxsbi_R1c5IGcUo8tWPbjYGTmPcVupA94MqedpYuleoMPdHKXLchMVGw4pVxMar-S8DPC2VnM9tKRjpxwI4iUHSgZ49OJtP5qfcFYilyYux1t07Nm7jEqx8t8J1zdOyocy_bQsBrdLo_D4oa52h5zO64qIafEBzvsoFd32O3KSXMqdPtPrtoock7aHLEGW-gyTcrTtDkHprcQ5P3oElTetB8wxVHYHIC5gP24d10OZkFbp-PQIvXWR2sdCbB_msdWZVBgKGVzFOdazAV2iSmVJEAjaKNLcEaGSnKFUYiRoVGCZNqGz9kh-vN2j5mHEZzo2xW5lkoykiDwrEwEGeRgMBHlEMW-BdcXBGdSwFhMAqk8AIpUCAFCWTIshtSKNzXvvvNTNmXVVE3yF4RqHHar6ZyL9cClD3-g6fWdrPfFVkKLjYGKUP2iOTdPkUU5mmehOLJv6_7lN3qPsln7LDe7u1zdrAz-xcO198A17jRyA
link.rule.ids 315,782,786,27933,27934,59868,60657,61275,61456
linkProvider Taylor & Francis
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07T8MwED5BGUBCUN7l6YE1Ik2cOGGrSlERtAsgsVmO7QBDW0Ta_89dnFQ8BEiI1co5in2P7y7nzwCnVgehiIj5MUcN5porL-GR9SKDYCM2fmpK2sX-rRg-JBc9osnp1GdhqK2ScujcEUWUvpqMm4rRZ2WK6adnbWK1QmjhOrMijMF03HeJqMaTBix1ur3hoHbHYcJTR5oaxR4JufNz387zIT41K_bSp3kv1idG0-9xaRmfLtf_4cuasFaBU9Zx2rQBC3a8CauussfcgaUteHQ-s3gumKr21hpG9Vw2oy41NskZKkKGEyGGHY0wNrIXxyuLEkT3QTzOtUhB9229KnzKnjPFNAZVRlZhi224v-zddftedV2Dp3lbTL1ciwTduNaBVQJxolZJGutUo8VrE5lMBRwVQxtM3_22SXiWE6A0yjeKm1jbcAca48nY7gHD0dQoK7JU-DwLNOqNxYFQBBzxK89a4NWbJF8cK4fEbIaWUNZLKGkJpVvCFogvOykrYy1-kUze77eclnWU3F16QmI_ibJaNyTaLP2IUWM7mRVSxIiUCGu2YNfpzPwrAkwp08jn-39_7wks9-8GN_Lmanh9ACtlu0PZfXgIjenrzB7BYmFmx5WdvAEwlw8_
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA66gQii8z6vefC12LVp0_o2dmGiDkEF30KapOrDLqzr__ecph1emIK-hp6UnpzLd9KTL4RcGOX5PEDmxxQsmCkmnYgFxgk0gI1Qu7EuaBcHD3z4HHV7SJOzOMWPbZVYQ6eWKKKI1ejcU51eFhWmG1-2kNQKkIVtzAogBeNp3zpA8QDKr3q70xveVdHYj1hsOVOD0EEhe3xu6Tyf0lOjJC99XbRifSE0XQ5Li_TU3_r_hzXIZglNadva0jZZMeMdsmH39ag9rrRLXmzEzN4yKsuVNZribi7NsUeNTlIKZpDARIBgRyPIjHRqWWVBAsk-kMW5Esnwtq2ZhKfMFZVUQUql6BMm2yNP_d5jZ-CUlzU4irX43EkVjyCIK-UZyQElKhnFoYoV-LvSgU6kx8AslIbi3W3piCUpwkktXS2ZDpXx90ltPBmbQ0JhNNbS8CTmLks8BVZjYMDnHgP0ypImcao1ElPLySGglkEVikqFAlUorAqbhH9bSFG6avaLZPRxucW82EVJ7ZUnKPaTKK1MQ4DH4m8YOTaTPBM8BJyESLNJDqzJLL7Cg4IyDlx29Pf3npO1-25f3F4Pb47JetHrULQenpDafJabU7Ka6fys9JJ3xh4N4w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Psychosis+associated+with+usage+of+herbal+slimming+products+adulterated+with+sibutramine%3A+a+case+series&rft.jtitle=Clinical+toxicology+%28Philadelphia%2C+Pa.%29&rft.au=Chen%2C+Sammy+P.L.&rft.au=Tang%2C+Magdalene+H.Y.&rft.au=Ng%2C+Sau+Wah&rft.au=Poon%2C+Wing+Tat&rft.date=2010-10-01&rft.pub=Taylor+%26+Francis&rft.issn=1556-3650&rft.eissn=1556-9519&rft.volume=48&rft.issue=8&rft.spage=832&rft.epage=838&rft_id=info:doi/10.3109%2F15563650.2010.517208&rft.externalDocID=517208
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1556-3650&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1556-3650&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1556-3650&client=summon